Quality of life in patients with prostate cancer

Seminars in oncology nursing

Volumn 17, Issue 2, 2001, Pages 138-146

  McPherson, Carol P ^a   Swenson, Karen K ^a   Kjellberg, Janice ^a  

^a PARK NICOLLET INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTITUDE TO HEALTH; CLINICAL TRIAL; HUMAN; IMPOTENCE; MALE; MORTALITY; PATHOLOGY; PROSTATE TUMOR; PROSTATECTOMY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RADIOTHERAPY; RECTUM DISEASE; URINE INCONTINENCE;

CLINICAL TRIALS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMPOTENCE; MALE; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIOTHERAPY; RECTAL DISEASES; URINARY INCONTINENCE;

EID: 0035344393     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-2081(01)80021-8     Document Type: Article

References (86)

1. Greenlee RT Murray T Bolden S Cancer statistics, 2000 CA Cancer J Clin 50 2000 7 33
2. Ries LAG Eisner MP Kosary CL SEER Cancer Statistics Review, 1973–1977 2000 National Cancer Institute Bethesda, MD
3. Middleton RG Thompson IM Austenfeld MS Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer J Urol 154 1995 2144 2148
4. Mettlin CJ Murphy GP McDonald CJ The National Cancer Data Base report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the US Cancer 86 1999 1877 1882
5. Albertsen PC Hanley JA Gleason DF Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer JAMA 280 1998 975 980
6. Litwin MS Lubeck DP Henning JM Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: Results of the CaPSURE database J Urol 159 1998 1988 1992
7. DeSilva FC Fossa SD Aaronson NK The quality of life of patients with newly diagnosed M1 prostate cancer: Experience with EORTC clinical trial 30853 Eur J Cancer 32A 1996 72 77
8. Litwin MS McGuigan KA Accuracy of recall in health-related quality-of life assessment among men treated for prostate cancer J Clin Oncol 17 1999 2882 2888
9. Talcott JA Quality of life in early prostate cancer: Do we know enough to treat? Hematol Oncol Clin North Am 10 1996 691 701
10. Litwin MS Health-related quality of life after treatment for localized prostate cancer Cancer 75 1995 2000 2003
11. Litwin MS Hays RD Fink A Quality-of-life outcomes in men treated for localized prostate cancer JAMA 273 1995 129 135
12. Shrader-Bogen CL Kjellberg JL McPherson CP Quality of life and treatment outcomes: Prostate cancer patients' perspectives after prostatectomy or radiation therapy Cancer 79 1997 1977 1986
13. Kao T Cruess DF Garner D Multicenter patient self-reporting questionnaire on impotence, incontinence, and stricture after radical prostatectomy J Urol 163 2000 858 864
14. Krupski T Petroni GR Bissonette EA Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer Urology 55 2000 736 742
15. Schag CAC Heinrich RL Development of a comprehensive quality of life measurement tool: CARES Oncology 4 1990 135 138
16. Sharp LK Knight SJ Nadler R Quality of life in low-income patients with metastatic prostate cancer: Divergent and convergent validity of three instruments Qual Life Res 8 1999 461 470
17. Aaronson NK Ahmedzai S Bergman B The EORTC QLQ-C30: A quality of life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
18. Curran D Fossa S Aaronson N Baseline quality of life of patients with advanced prostate cancer Eur J Cancer 33 1997 1809 1814
19. Fossa SD Woehre H Kurth KH Influence of urological morbidity on quality of life in patients with prostate cancer Eur Urol 31 suppl 3 1997 3 8
20. Version 3 Cella DR FACT Manual 1996 Rush-Presbyterian-St Luke's Medical Center Chicago, IL
21. Ferrans CE Development of a quality of life index for patients with cancer Oncol Nurs Forum 17 suppl 3 1990 15 19
22. Schipper H Clinch J McMurray A Measuring the quality of life of cancer patients: The functional living index—cancer: Development and validation J Clin Oncol 2 1984 472 483
23. McNair DM Lorr M Droppleman LF Profile of Mood States (POMS) Manual 1992 Educational and Industrial Testing Service San Diego, CA
24. Rosendahl I Kiebert GM Curran D Quality-adjusted survival (Q-TwiST) analysis of EORTC Trial 30853: Comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer Prostate 38 1999 100 109
25. DeHaes JCJM von Knippenberg FCE Neijt JP Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist Br J Cancer 62 1990 1034 1038
26. Hays RD Sherbourne CD The RAND 36-Item Health Survey 1.0 Med Care 2 1993 217
27. Clark JA Wray N Brody B Dimensions of quality of life expressed by men treated for metastatic prostate cancer Soc Sci Med 45 1997 1299 1309
28. Borghede G Karlsson J Sullivan M Quality of life in patients with prostatic cancer: Results from a Swedish population study J Urol 158 1997 1477 1486
29. Esper P Mo F Chodak G Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy—Prostate instrument Urology 50 1997 920 928
30. Donovan JL Abrams P Peters TJ The ICS-‘BPH’ Study: The psychometric validity and reliability of the ICS male questionnaire Br J Urol 77 1996 554 563
31. Barry MJ Fowler FJ Jr O'Leary MP The American Urological Association Symptom Index for benign prostatic hyperplasia J Urol 148 1992 1549 1557
32. Derogadis LR Lopez M PAIS and PAIS-SR: Administration, Scoring and Procedures 1993 Clinical Psychometric Research Baltimore, MD
33. Fowler FL Roman A Barry MJ Patient-reported complications and follow-up treatment after radical prostatectomy Urology 42 1993 622 629
34. Fowler FJ Barry MJ Lu-Yao G Outcomes of external-beam radiation therapy for prostate cancer: A study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas J Clin Oncol 14 1996 2258 2265
35. Stockler MR Osoba D Goodwin P Respnsiveness to change in health-related quality of life in a randomized clinical trial: A comparison of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) with analogous scales from the EORTC QLQ-C30 and a trial specific module J Clin Epidemiol 51 1998 137 145
36. Moinpour CM Hayden KA Thompson IM Quality of life assessment in Southwest Oncology Group trials Oncology 4 1990 79 84
37. Litwin MS Hays RD Fink A The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure Med Care 36 1998 1002 1012
38. Bates TS Wright MPJ Gillatt DA Prevalence and impact of incontinence and impotence following total prostatectomy assessed anonymously by the ICS-male questionnaire Eur Urol 33 1998 165 169
39. Braslis KG Santa-Cruz CS Brickman AL Quality of life 12 months after radical prostatectomy Br J Urol 75 1995 48 53
40. Heathcote PS Mactaggart PN Boston RJ Health-related quality of life in Australian men remaining disease-free after radical prostatectomy Med J Aust 168 1998 483 486
41. Jonler M Madsen FA Rhodes PR A prospective study of quantification of urinary incontinence and quality of life in patients undergoing radical retropubic prostatectomy Urology 48 1996 433 440
42. Lilleby W Fossa SD Waehre HR Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy Int J Radiat Oncol Biol Phys 43 1999 735 743
43. McCammon KA Kolm P Main B Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer Urology 54 1999 509 516
44. Stanford JL Feng Z Hamilton AS Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study JAMA 283 2000 354 360
45. Smith DS Carvalhal GF Schneider K Quality-of-life outcomes for men with prostate carcinoma detected by screening Cancer 88 2000 1454 1463
46. Talcott JA Rieker P Propert KJ Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy J Natl Cancer Inst 89 1997 1117 1123
47. Talcott JA Rieker P Clark JA Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study J Clin Oncol 16 1998 275 283
48. Yarbro CH Ferrans CE Quality of life of patients with prostate cancer treated with surgery or radiation therapy Oncol Nurs Forum 25 1998 685 693
49. Lim AJ Brandon AH Fiedler J Quality of life radical prostatectomy versus radiation therapy for prostate cancer J Urol 154 1995 1420 1425
50. Carvalhal GF Smith DS Ramos C Correlates of dissatisfaction with treatment in patients with prostate cancer diagnosed through screening J Urol 162 1999 113 118
51. Lubeck DP Litwin MS Henning JM Changes in health-related quality of life in the first year after treatment for prostate cancer: Results from CaPSURE Urology 53 1999 180 186
52. Mantz CA Nautiyal J Awan A Potency preservation following conformal radiotherapy for localized prostate cancer: Impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors Cancer J Sci Am 5 1999 230 236
53. Gralnek D Wessells H Cui H Differences in sexual function and quality of life after nerve sparing and nonnerve sparing radical retropubic prostatectomy J Urol 163 2000 1166 1170
54. Zelefsky MJ Wallner KE Ling CG Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer J Clin Oncol 17 1999 517 522
55. Caffo O Fellin G Graffer U Assessment of quality of life after radical radiotherapy for prostate cancer Br J Urol 78 1996 557 563
56. Jonler M Ritter MA Brinkmann R Sequelae of definitive radiation therapy for prostate cancer localized to the pelvis Urology 44 1994 876 882
57. Beard CJ Propert KJ Rieker PP Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: A prospective multiinstitutional outcomes study J Clin Oncol 15 1997 223 229
58. Beckendorf V Hay M Rozan R Changes in sexual function after radiotherapy treatment of prostate cancer Br J Urol 77 1996 118 123
59. Franklin CIV Parker CA Morton KM Late effects of radiation therapy for prostate carcinoma: The patient's perspective of bladder, bowel, and sexual morbidity Australas Radiol 42 1998 58 65
60. Fransson P Widmark A Self-assessed sexual function after pelvic irradiation for prostate carcinoma: Comparison with an age-matched control group Cancer 78 1996 1066 1078
61. Helgason AR Fredrikson M Adolfsson J Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life Int J Radiat Oncol Biol Phys 32 1995 33 39
62. Roach M Chinn DM Holland J A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer Int J Radiat Oncol Biol Phys 35 1996 869 874
63. Litwin MS Flanders SC Pasta DJ Sexual function and bother after radical prostatectomy or radiation for prostate cancer: Multivariate quality-of-life analysis from CaPSURE Urology 54 1999 503 508
64. Franklin CIV Acute morbidity of radiation therapy for prostate carcinoma Australas Radiol 40 1996 140 145
65. Huguenin PU Bitterli M Lutolf UM Localized prostate cancer in elderly patients: Outcome after radiation therapy compared to matched younger patients Strahlenther Onkol 175 1999 554 558
66. Joly F Brune D Couette JE Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer Ann Oncol 9 1998 751 757
67. Arterbery VE Frazier A Dalmia P Quality of life after permanent prostate implant Semin Surg Oncol 13 1997 461 464
68. Brandeis JM Litwin MS Burnison CM Quality of life outcomes after brachytherapy for early stage prostate cancer J Urol 163 2000 851 857
69. Lee WR McQuellon RP Harris-Henderson K A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer Int J Radiat Oncol Biol Phys 46 2000 77 81
70. Dattoli M Wallner K Sorace R Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma Int J Radiat Oncol Biol Phys 35 1996 875 879
71. Sharkey J Chovnick SD Behar RJ Outpatient ultrasound-guided palladium-103 brachytherapy for localized adenocarcinoma of the prostate: A preliminary report of 434 patients Urology 51 1998 796 803
72. Jonler M Nielsen OS Wolf H Urinary symptoms, potency, and quality of life in patients with localized prostate cancer followed up with deferred treatment Urology 52 1998 1055 1063
73. Robinson JW Saliken JC Donnelly BJ Quality-of-life outcomes for men treated with cryosurgery for localized prostate carcinoma Cancer 86 1999 1793 1801
74. Albertsen PC Aaronson NK Muller MJ Health-related quality of life among patients with metastatic prostate cancer Urology 49 1997 207 217
75. Herr HW Kornblith AB Ofman U A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy Cancer 71 1993 1143 1150
76. Bales GT Chodak GW A controlled trial of bicalutamide versus castration in patients with advanced prostate cancer Urology 47 suppl 1A 1996 38 53
77. Kaisary AV Tyrrell CJ Beacock C A randomised comparison of monotherapy with casodex 50 mg daily and castration in the treatment of metastatic prostate carcinoma Eur Urol 28 1995 215 222
78. Tyrrell CJ Kaisary AV Iversen P A randomised comparison of Casodex (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer Eur Urol 33 1998 447 456
79. Litwin MS Shpall AI Dorey F Quality of life outcomes in long-term survivors of advanced prostate cancer Am J Clin Oncol 21 1998 327 332
80. Popov I Jelic S Radosavljevic D Androgen level variations, clinical response to LHRH agonists and changes in the quality of life subscales in metastatic prostate cancer—Speculations about possible role of the monoamine system Neoplasma 44 1997 308 313
81. Schellhammer P Sharifi R Block N A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer Urology 45 1995 745 752
82. Moinpour CM Savage MJ Troxel A Quality of life in advanced prostate cancer: Results of a randomized therapeutic trial J Natl Cancer Inst 90 1998 1537 1544
83. DeReijke TM Keuppens FI Whelan P Orchiectomy and orchiectomy plus mitomycin C for metastatic prostate cancer in patients with poor prognosis: The final results of a European Organization for Research in Cancer Therapy Genitourinary Group Trial J Urol 162 1999 1658 1665
84. Moore MJ Osoba D Murphy K Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer J Clin Oncol 12 1994 689 694
85. Smith DC Esper P Strawderman M Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer J Clin Oncol 17 1999 1664 1671
86. Osoba D Tannock IF Ernst DS Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone J Clin Oncol 17 1999 1654 1663